Tetralogy of Fallot with anomalous origin of left anterior descending coronary artery. Surgical options.

Coronary arterial anatomy in tetralogy of Fallot: morphological and clinical correlations. Heart (1998) 1.00

Natural and unnatural history of tetralogy of Fallot repaired during adolescence and adulthood. Heart Vessels (2011) 0.82

Repair of tetralogy of Fallot with anomalous coronary arteries coursing across the obstructed right ventricular outflow tract. Pediatr Cardiol (2005) 0.75

Simplified double barrel repair with autologous pericardium for tetralogy of fallot with hypoplastic pulmonary annulus and anomalous coronary crossing right ventricular outflow. Ann Pediatr Cardiol (2008) 0.75

Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med (1990) 4.70

Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med (1993) 3.90

The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53

Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol (2001) 3.39

A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc Natl Acad Sci U S A (1999) 3.37

Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation (1999) 3.25

Klippel-Trénaunay syndrome: spectrum and management. Mayo Clin Proc (1998) 2.95

Calcific constrictive pericarditis: is it still with us? Ann Intern Med (2000) 2.81

Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints. Am J Hum Genet (1999) 2.71

Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation (1996) 2.67

Surgical treatment of vascular rings: the Mayo Clinic experience. Mayo Clin Proc (1993) 2.63

Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg (2005) 2.46

Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. Am J Hum Genet (1996) 2.41

Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet (1995) 2.34

Five- to fifteen-year follow-up after Fontan operation. Circulation (1992) 2.26

Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc (1995) 2.17

Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics (1989) 2.16

Surgical treatment of venous malformations in Klippel-Trénaunay syndrome. J Vasc Surg (2000) 2.12

Allele-specific replication timing of imprinted gene regions. Nature (1993) 2.08

Anomalous systemic venous connection. Surgical considerations. Mayo Clin Proc (1975) 2.06

Diagnostic role of Doppler echocardiography in constrictive pericarditis. J Am Coll Cardiol (1994) 2.05

Cor triatriatum dexter: two-dimensional echocardiographic diagnosis. J Am Coll Cardiol (1987) 1.95

Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet (1999) 1.93

Traumatic tricuspid valve insufficiency. Experience in thirteen patients. J Thorac Cardiovasc Surg (1994) 1.89

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85

Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet (1993) 1.84

A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82

Prosthetic valve endocarditis. Ann Intern Med (1975) 1.78

Cor triatriatum: diagnosis, operative approach, and late results. Mayo Clin Proc (1993) 1.77

Minimal definition of the imprinting center and fixation of chromosome 15q11-q13 epigenotype by imprinting mutations. Proc Natl Acad Sci U S A (1996) 1.76

Partial anomalous pulmonary venous connection: diagnosis by transesophageal echocardiography. J Am Coll Cardiol (1997) 1.72

Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet (2001) 1.71

A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum Mol Genet (1999) 1.69

Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg (1996) 1.65

Surgical pathology of the pulmonary valve: a study of 116 cases spanning 15 years. Mayo Clin Proc (1989) 1.61

Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation (1996) 1.59

Cytogenetic and molecular analysis in Angelman syndrome. Am J Med Genet (1993) 1.58

Impact of 2-Dimensional echocardiography on the management of distressed newborns in whom cardiac disease is suspected. Am J Cardiol (1983) 1.56

Modified Fontan operation for univentricular heart and complicated congenital lesions. J Thorac Cardiovasc Surg (1979) 1.56

Diagnosis of sinus venosus atrial septal defect with transesophageal echocardiography. Circulation (1996) 1.54

Long-term outcome of surgical repair of ruptured sinus of Valsalva aneurysm. Circulation (1994) 1.53

Cardiac transplantation for end-stage congenital heart defects: the Mayo Clinic experience. Mayo Cardiothoracic Transplant Team. Mayo Clin Proc (1998) 1.53

Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg (2001) 1.52

Safety and utility of endomyocardial biopsy in infants, children and adolescents: a review of 66 procedures in 53 patients. J Am Coll Cardiol (1990) 1.51

Operation for partial atrioventricular septal defect: a forty-year review. J Thorac Cardiovasc Surg (2000) 1.49

Modification of 15q11-q13 DNA methylation imprints in unique Angelman and Prader-Willi patients. Hum Mol Genet (1993) 1.49

Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation (1993) 1.45

Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol (1983) 1.45

Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg (1985) 1.43

Klippel-Trenaunay syndrome: current management. Phlebology (2007) 1.43

Late results of valve replacement with the Björk-Shiley valve (1973 to 1982) J Thorac Cardiovasc Surg (1993) 1.43

Ebstein's anomaly - review of a multifaceted congenital cardiac condition. Swiss Med Wkly (2005) 1.43

Aneurysm of aortic cannulation site. Successful repair by means of peripheral cannulation, profound hypothermia, and circulatory arrest. J Thorac Cardiovasc Surg (1971) 1.40

Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac Cardiovasc Surg (2000) 1.40

Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature. Arch Pathol Lab Med (1990) 1.39

The modified Fontan operation. J Thorac Cardiovasc Surg (1989) 1.38

Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci (2005) 1.37

Prosthetic valve endocarditis. Mayo Clin Proc (1982) 1.36

Management of symptomatic infants with anomalous origin of the left coronary artery from the pulmonary artery. Am J Cardiol (1981) 1.36

Mediastinal hemorrhage from parathyroid adenoma simulating dissecting aneurysm. Arch Surg (1974) 1.36

Asymptomatic giant right atrial aneurysm. Tex Heart Inst J (2001) 1.35

The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. J Thorac Cardiovasc Surg (1995) 1.32

Aorta-coronary artery saphenous vein bypass surgery: clinical and angiographic results. Mayo Clin Proc (1975) 1.31

Open-heart surgery in patients more than 65 years old. Ann Thorac Surg (1974) 1.30

Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes. Mol Hum Reprod (1997) 1.30

Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle. J Am Coll Cardiol (1986) 1.29

Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. Hum Mol Genet (1999) 1.28

Successful treatment of aortic valve endocarditis and aortic root abscesses by insertion of prosthetic valve in ascending aorta and placement of bypass grafts to coronary arteries. J Thorac Cardiovasc Surg (1974) 1.25

Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol (1985) 1.24

Hemodynamic response to positive end-expiratory pressure following right atrium-pulmonary artery bypass (Fontan procedure). J Thorac Cardiovasc Surg (1984) 1.22

Nylon bands for closure of median sternotomy incisions: an unacceptable method. Ann Thorac Surg (1972) 1.22

Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg (1985) 1.22

Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation (1999) 1.22

Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992. J Am Coll Cardiol (1996) 1.21

Molecular mechanism of angelman syndrome in two large families involves an imprinting mutation. Am J Hum Genet (1999) 1.21